Axial Spondyloarthritis in Inflammatory Bowel Disease – secondary care cross-sectional prevalence and development of an evidence-base referral tool [Norfolk - Axial SPa Ibd REferral Tool (N-ASPIRE Tool)]

orfolk and Norwich University Hospitals NHS Foundation Trust0 个研究点目标入组 470 人开始时间: 2018年4月20日最近更新: 2022年9月12日

试验速览

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35993905/ (added 30/08/2022)

•Inclusion criteria for Phase 1 (Screening):
•1. Gastroenterologist verified diagnosis of inflammatory bowel disease (Crohn’s disease or Ulcerative colitis, with either endoscopic, radiological or histological evidence of disease based on established criteria)
•2. Age = 18 and = 80 years old
•3. Patient willing and able to participate in the study
•4. Including known/previous diagnosis of AS or axSpA
•Inclusion criteria for Phase 2 (Clinical assessment):
•1. Chronic back pain (= 3 months)
•2. Onset of back pain before 45 years old
•3. Including known/previous diagnosis of AS or axSpA (if unable to verify diagnosis retrospectively)

•1. Any type of biologic therapy for (previous or current) treatment of IBD
•2. Unable to tolerate MRI scanning (e.g. current history of claustrophobia) or contra-indication to MRI scanning
•(including but not limited to e.g. pacemaker, pregnancy, metallic or conducting foreign body, etc.)
•3. Age <18 or >80 years
•4. Patients lacking in capacity and/or unable to give informed consent
•5. Patients unable to understand English to sufficient degree to be able to complete a questionnaire
•6. Illiteracy
•7. Prisoners
•8. Patient unwilling to take part in the study

发起方